Human Proto-Oncogene c- jun Encodes a DNA Binding Protein with Structural and Functional Properties of Transcription Factor AP-1
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Nuclear oncogene products have the potential to induce alterations in gene regulation leading to the genesis of cancer. The biochemical mechanisms by which nuclear oncoproteins act remain unknown. Recently, an oncogene, v- jun , was found to share homology with the DNA binding domain of a yeast transcription factor, GCN4. Furthermore, GCN4 and the phorbol ester-inducible enhancer binding protein, AP-1, recognize very similar DNA sequences. The human proto-oncogene c- jun has now been isolated, and the deduced amino acid sequence indicates more than 80 percent identity with v- jun . Expression of cloned c- jun in bacteria produced a protein with sequence-specific DNA binding properties identical to AP-1. Antibodies raised against two distinct peptides derived from v- jun reacted specifically with human AP-1. In addition, partial amino acid sequence of purified AP-1 revealed tryptic peptides in common with the c- jun protein. The structural and functional similarities between the c- jun product and the enhancer binding protein suggest that AP-1 may be encoded by c- jun . These findings demonstrate that the proto-oncogene product of c- jun interacts directly with specific target DNA sequences to regulate gene expression, and therefore it may now be possible to identify genes under the control of c- jun that affect cell growth and neoplasia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“c-Jun belongs to the bZIP group of DNA binding proteins and is a component of AP-1 transcription factor complexes (17).”
From c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor (1999) · cites this paper as [17]
In the citing paper
“The c-Jun promoter contains important TPA response elements that preferentially bind heterodimers of c-Jun and ATF-2, both of which are activated upon phosphorylation by JNK (17)(18)(19).”
From c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor (1999) · cites this paper as [17]
In the citing paper
“Usually, c-Jun forms heterodimers with c-Fos in AP-1 transcription factor complexes (17)(18)(19).”
From c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor (1999) · cites this paper as [17]
In the citing paper
“C-JUN is a proto-oncogene which is regulated by c-JUN N-terminal Kinases (JNKs) [48, 49], a sub-family of MAPKs activated by environmental stress, inflammatory cytokines and growth factors.”
From Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer (2025) · cites this paper as [49]
In the citing paper
“c-Jun belongs to the bZIP (basic leucine zipper) group of DNA binding proteins and is a component of AP-1 transcription factor complexes [69].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [69]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R. J., Rahmsdorf, H. J., Jonat, C., Herrlich, P., & Karin, M. (1987) · Cell · doi:10.1016/0092-8674(87)90611-8 · Cited by 2,931
Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes.
Miller, J., McLachlan, A. D., & Klug, A. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03825.x · Cited by 2,476
Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements
Lee, W., Mitchell, P., & Tjian, R. (1987) · Cell · doi:10.1016/0092-8674(87)90612-x · Cited by 1,983
Self-citationArriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
The Molecular Genetics of Cancer
Bishop, J. M. (1987) · Science · doi:10.1126/science.3541204 · Cited by 1,688
CELLULAR ONCOGENES AND RETROVIRUSES
Bishop, J. M. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.001505 · Cited by 1,641
Kadonaga, J. T., Carner, K. R., Masiarz, F. R., & Tjian, R. (1987) · Cell · doi:10.1016/0092-8674(87)90594-0 · Cited by 1,616
Self-citationPabo, C. O., & Sauer, R. T. (1984) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.53.070184.001453 · Cited by 1,569
Affinity purification of sequence-specific DNA binding proteins.
Kadonaga, J. T., & Tjian, R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.5889 · Cited by 1,154
Self-citationMitchell, P. J., Wang, C., & Tjian, R. (1987) · Cell · doi:10.1016/0092-8674(87)90512-5 · Cited by 931
Self-citation
Research works printed but not linked: 1
- VARMUS, H, ANN REV GENET 18: 353 (1984).
Cited by
Items 501–600 of 1,002
Programmed cell death in an estrogen-independent human breast cancer cell line, MDA-MB-468.
Armstrong, D. K., Isaacs, J. T., Ottaviano, Y. L., & Davidson, N. E. (1992) · PubMed · Cited by 70
Growth Factor Inducible Genes in Fibroblasts
Bravo, R. (1990) · Springer eBooks · doi:10.1007/978-3-642-74856-1_24 · Cited by 73
Shin, E., Nah, S., Kim, W., Ko, K. H., Jhoo, W., Lim, Y., Cha, J. Y., Chen, C., & Kim, H. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705998 · Cited by 66
“The cRNA probes for c-fos (Curran et al., 1987), c-jun (Boham et al., 1987) and GAPDH (Fort et al., 1985) were synthesized in vitro from linearized expression vector using DIG-UTP, as suggested by the manufacturer (Boehringer Mannheim, Germany).”
MethodCritical role of c-Jun overexpression in liver metastasis of human breast cancer xenograft model
Zhang, Y., Pu, X., Shi, M., Chen, L., Song, Y., Lu, Q., Yuan, G., Zhang, H., Yu, M., Hu, M., et al. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-145 · Cited by 72
“Background The composite transcription factor activating protein-1 (AP-1) is thought to participate in fundamental cellular processes and control cellular responses to stimuli that regulate proliferation, differentiation, oncogenic transformation and apoptosis [1-5].”
BackgroundInhibitions of protein kinase C and proto-oncogene expressions in NIH 3t3 cells by apigenin
Huang, Y.-T., Kuo, M., Liu, J.-Y., Huang, S.-Y., & Lin, J. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00540-4 · Cited by 75
Hoeffler, J. P., Meyer, T. E., Waeber, G., & Habener, J. F. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-6-920 · Cited by 69
Fujiwara, S., Fisher, R. J., Bhat, N. K., Diaz de la Espina, S. M., & Papas, T. S. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.11.4700 · Cited by 69
“Another nuclear oncogene, jun, was recently shown to code for a transcriptional activator protein, AP-1 (5).”
BackgroundInfluentialMugnaini, E., Berrebi, A. S., Morgan, J. I., & Curran, T. (1989) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1989.tb00773.x · Cited by 68
Regulation of gene expression by tumor promoters
Rahmsdorf, H. J., & Herrlich, P. A. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90079-h · Cited by 72
Gene Regulation by Tyrosine Kinases: src Protein Activates Various Promoters, Including c- fos
Fujii, M., Shalloway, D. I., & Verma, I. M. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.6.2493-2499.1989 · Cited by 69
“sequence referred to as the TPA (12-o-tetradecanoylphorbol13-acetate) responsive element (TRE) (4).”
BackgroundQu, W., Diwan, B. A., Reece, J. M., Bortner, C. D., Pi, J., Liu, J., & Waalkes, M. P. (2004) · International Journal of Cancer · doi:10.1002/ijc.20736 · Cited by 71
Altered Gene Transcription After Burn Injury Results in Depressed T-Lymphocyte Activation
Horgan, A. F., Mendez, M. V., O'Riordain, D. S., Holzheimer, R. G., Mannick, J. A., & Rodrick, M. L. (1994) · Annals of Surgery · doi:10.1097/00000658-199409000-00010 · Cited by 68
Wang, Y., Kobori, J. A., & Hood, L. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.9.5691-5701.1993 · Cited by 65
Karpinski, B. A., Yang, L., Cacheris, P., Morle, G. D., & Leiden, J. M. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.6.2588-2597.1989 · Cited by 70
“In contrast, the AP-lIc-jun gene product (2, 6) (and its cognate sequence) has previously been shown to be responsible for the phorbol ester inducibility of a number of genes (3, 22), including the human metallothionein "A gene and the collagenase gene (40).”
BackgroundIsolation and characterization of a TATA-less promoter for the human beta 3 integrin gene
Villa‐Garcia, M., Li, L. A., Riely, G. J., & Bray, P. (1994) · Blood · doi:10.1182/blood.v83.3.668.668 · Cited by 68
Szabo, E. M., Preis, L. H., Brown, P. H., & Birrer, M. J. (1991) · PubMed · Cited by 77
O'Brien, R. M., Bonovich, M. T., Forest, C. D., & Granner, D. K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6580 · Cited by 66
The JNK pathway amplifies and drives subcellular changes in tau phosphorylation
Vogel, J. W., Anand, V. S., Ludwig, B., Nawoschik, S. P., Dunlop, J., & Braithwaite, S. P. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.021 · Cited by 68
“An upstream kinase signaling cascade leads to the phosphorylation of JNKs, that prototypically translocate to the nucleus where they phosphorylate transcription factors including c-jun which are involved in transcription of genes involved in a diverse array of cellular processes including cellular growth and apoptosis…”
BackgroundCombining structure-based design with phage display to create new Cys2His2 zinc finger dimers
Wolfe, S. A., Ramm, E. I., & Pabo, C. O. (2000) · Structure · doi:10.1016/s0969-2126(00)00161-1 · Cited by 70
Lee, S. F., & Lin, J. (1997) · Nutrition and Cancer · doi:10.1080/01635589709514572 · Cited by 65
Fitzgerald, T., Neale, G., Raimondi, S., & Goorha, R. (1991) · Blood · doi:10.1182/blood.v78.10.2686.2686 · Cited by 65
Morgan, J. I., & Curran, T. (1990) · Progress in brain research · doi:10.1016/s0079-6123(08)63185-4 · Cited by 68
Kainate‐Induced Changes in Opioid Peptide Genes and AP‐1 Protein Expression in the Rat Hippocampus
Pennypacker, K. R., Walczak, D., Thai, L., Fannin, R. D., Mason, E., DOUGLASS, J. O., & Hong, J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb05839.x · Cited by 69
Zolnierowicz, S., Cron, P., Solinas-Toldo, S., Fries, R., Lin, H. Y., & Hemmings, B. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32201-9 · Cited by 66
Enhancers and transcription factors in the control of gene expression
Wasylyk, B. (1988) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(88)90021-8 · Cited by 76
Only one of the two DNA-bound orientations of AP-1 found in solution cooperates with NFATp
Chen, L., Oakley, M. G., Mark Glover, J. N., Jain, J., B. Dervan, P., Hogan, P. G., Rao, A., & Verdine, G. L. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00178-3 · Cited by 64
“The sequences are numbered in accordance with the sequences of human cJun [38] and human cFos [39].”
BackgroundThe cellular basis for liver injury in α1-antitrypsin deficiency
Perlmutter, D. H. (1991) · Hepatology · doi:10.1002/hep.1840130125 · Cited by 71
The Leucine Zipper of c-Myc Is Required for Full Inhibition of Erythroleukemia Differentiation
Smith, M. J., Charron‐Prochownik, D., & Prochownik, E. V. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.10.5333 · Cited by 68
Degradation of E2A Proteins through a Ubiquitin-conjugating Enzyme, UbcE2A
Kho, C.-J., Huggins, G. S., Endege, W. O., Hsieh, C.-M., Lee, M.-E., & Haber, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3845 · Cited by 64
Mollinedo, F., Gajate, C., Tugores, A., Flores, I., & Naranjo, J. R. (1993) · Biochemical Journal · doi:10.1042/bj2940137 · Cited by 63
Mayers, D. L., Mikovits, J. A., Joshi, B. H., HEWLETT, I. K., Estrada, J. S., Wolfe, A. D., Garcia, G. E., Doctor, B. P., Burke, D. S., & Gordon, R. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.1.215 · Cited by 69
Brown, P. H., Kim, S. H., Wise, S., Sabichi, A. L., & Birrer, M. J. (1996) · PubMed · Cited by 70
Feng, P., Ohlsson, M., & Ny, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39934-x · Cited by 65
Mechanisms of normal and malignant breast epithelial growth regulation
Lippman, M. E., & Dickson, R. B. (1989) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(89)90071-x · Cited by 62
Conservation and evolution of transcriptional mechanisms in eukaryotes
Guarente, L., & Bermingham‐McDonogh, O. (1992) · Trends in Genetics · doi:10.1016/0168-9525(92)90021-u · Cited by 62
Simek, S. L., & Rice, N. R. (1988) · Journal of Virology · doi:10.1128/jvi.62.12.4730-4736.1988 · Cited by 62
de Groot, R. P., Schoorlemmer, J., Ganesen, S. T. V., & Kruijer, W. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.11.3195 · Cited by 65
Cloning and analysis of the CD18 promoter
Rosmarin, A., Levy, R., & Tenen, D. (1992) · Blood · doi:10.1182/blood.v79.10.2598.2598 · Cited by 60
Phosphorylation of cellular proteins regulates their binding to the cAMP response element
Merino, A., Buckbinder, L., Mermelstein, F. H., & Reinberg, D. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)30075-4 · Cited by 66
Wasylyk, B., Imler, J., Chatton, B., Schatz, C., & Wasylyk, C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.7952 · Cited by 66
Foster, N., Lea, S. R., Preshaw, P. M., & Taylor, J. J. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0206086 · Cited by 61
“Furthermore, c-Jun, which has autonomous, transcriptional activity and activity as part of the activator protein 1 complex [35], has also been shown to synergize with PU.”
BackgroundHafeez, W., Ciliberto, G., & Perlmutter, D. H. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115705 · Cited by 69
Yamauchi, M., Ogata, Y., Kim, R. H., Li, J. J., Freedman, L. P., & Sodek, J. (1996) · Matrix Biology · doi:10.1016/s0945-053x(96)90153-5 · Cited by 63
Severynse-Stevens, D., Hutchison, C. A., & Edgell, M. H. (1991) · Mammalian Genome · doi:10.1007/bf00570439 · Cited by 61
“6, region C) which is recognized by c-Jun or Jun/Fos heterodimers (Bohmann et al. 1987; Kouzarides and Ziff 1988).”
BackgroundTang, Z., Treilleux, I., & Brown, M. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1274 · Cited by 61
“Many transcription factors are known to bind to an AP-1 site, including c-Fos and c-Jun (3).”
BackgroundThalidomide, a current teratogen in South America
Castilla, E. E., Ashton‐Prolla, P., Barreda‐Mejia, E., Brunoni, D., Cavalcanti, D. P., Correa‐Neto, J., Delgadillo, J. L., Dutra, M. G., Felix, T., Giraldo, A., et al. (1996) · Teratology · doi:10.1002/(sici)1096-9926(199612)54:6<273::aid-tera1>3.0.co;2-# · Cited by 105
Nuclear Retinoid Receptors and Their Mechanism of Action
Pfahl, M., Apfel, R., Bendik, I., Fanjul, A. N., Graupner, G., Lee, M., La-Vista, N., Lu, X., Piedrafita, F. J., Ortiz, M. A., et al. (1994) · Vitamins and hormones · doi:10.1016/s0083-6729(08)61150-4 · Cited by 66
Birkenkamp, K., Dokter, W., Esselink, M., Jonk, L., Kruijer, W., & Vellenga, E. (1999) · Leukemia · doi:10.1038/sj.leu.2401447 · Cited by 61
Cloning and analysis of the CD18 promoter
Rosmarin, A., Levy, R., & Tenen, D. (1992) · Blood · doi:10.1182/blood.v79.10.2598.bloodjournal79102598 · Cited by 60
Wong, S.-S., Zhou, H.-R., & Pestka, J. J. (2002) · Journal of Toxicology and Environmental Health · doi:10.1080/152873902760125381 · Cited by 60
“Phosphorylation of c-Jun and c-Fos protein has been shown to increase the transactivation of AP-1 (Bohmann et al., 1987).”
BackgroundHo, N. Y., Gullberg, M., & Chatila, T. A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.1.101 · Cited by 60
Hinnebusch, A. G. (1990) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)60712-6 · Cited by 60
Michel, J. B., Ordway, G. A., Richardson, J. A., & Williams, R. S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117318 · Cited by 62
Trans-dominant negative mutants of Fos and Jun.
Ransone, L. J., Visvader, J. E., Wamsley, P., & Verma, I. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3806 · Cited by 64
Regulation of Human Immunodeficiency Virus Infection: Implications For Pathogenesis
Antoni, B. A., Stein, S., & Rabson, A. B. (1994) · Advances in virus research · doi:10.1016/s0065-3527(08)60047-0 · Cited by 71
Expression of c-jun during macrophage differentiation of HL-60 cells
Gaynor, R., Simon, K., & Koeffler, P. (1991) · Blood · doi:10.1182/blood.v77.12.2618.2618 · Cited by 59
Dominant negative effect of a germ-line mutant p53: a step fostering tumorigenesis.
Srivastava, S., Wang, S., Tong, Y. A., Hao, Z., & Chang, E. H. (1993) · PubMed · Cited by 59
Transcriptional activation of yeast nucleotide biosynthetic gene ADE4 by GCN4.
Mösch, H., Scheier, B., Lahti, R., Mäntsälä, P., & Braus, G. H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54945-0 · Cited by 59
Goals for signal transduction pathways: linking up with transcriptional regulation.
Sassone‐Corsi, P. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06797.x · Cited by 64
Day, M. L., Fahrner, T. J., Aykent, S., & Milbrandt, J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77249-9 · Cited by 63
Nerve growth factor employs multiple pathways to induce primary response genes in PC12 cells.
Batistatou, A. K., Volonté, C., & Greene, L. A. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.3.363 · Cited by 59
Andoh, A., Takaya, H., Makino, J., Sato, H., Bamba, S., Araki, Y., Hata, K., Shimada, M., Okuno, T., Fujiyama, Y., et al. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2001.01588.x · Cited by 58
Coactivator MBF1 preserves the redox‐dependent AP‐1 activity during oxidative stress in Drosophila
Jindra, M., Gažiová, I., Uhlířová, M., Okabe, M., Hiromi, Y., & Hirose, S. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600356 · Cited by 63
“Exactly such substitution is found in the viral transforming protein v-Jun (Bohmann et al, 1987; Maki et al, 1987), where it contributes to the oncogenic activity synergistically with other mutations (Morgan et al, 1994).”
BackgroundNagase, T., Mizugachi, G., Nomura, N., Ishizaki, R., Ueno, Y., & Ishii, S. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.2.337 · Cited by 65
Than, N. G., Sümegi, B., Bellyei, S., Berki, T., Szekeres, G., Janáky, T., Szigeti, A., Bohn, H., & Than, G. N. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03475.x · Cited by 63
Regulation of c-fos and c-jun expression in the rat supraoptic nucleus
Carter, D., & Murphy, D. (1990) · Cellular and Molecular Neurobiology · doi:10.1007/bf00711185 · Cited by 58
“The major protein in purified preparations of transcription factor AP-1 is Jun, the product of c-jun gene (Bohmann et al., 1987), although other related gene products are present which also form transcription complexes with Fos (Nakabeppu et al.”
BackgroundStructural Organization of the Human Mitochondrial Cytochrome c1 Gene
Suzuki, H., Hosokawa, Y., Nishikimi, M., & Ozawa, T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94196-7 · Cited by 59
Sherr, C. J. (1988) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(88)90011-x · Cited by 70
Structure and Regulation of the Multigene Family Controlling Maltose Fermentation in Budding Yeast
Vanoni, M., Sollitti, P., Goldenthal, M. J., & Marmur, J. (1989) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)60701-1 · Cited by 58
Isolation and characterization of the 5′ flanking region of the mouse C‐harvey‐ras gene
Brown, K., Bailleul, B., Ramsden, M., Krumlauf, R. K., & Balmain, A. (1988) · Molecular Carcinogenesis · doi:10.1002/mc.2940010304 · Cited by 58
Ferrer, I., Olivé, M., Blanco, R., Cinós, C., & Planas, A. M. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00334-o · Cited by 57
Baranes, D., & Razin, E. (1991) · Blood · doi:10.1182/blood.v78.9.2354.2354 · Cited by 57
Kubek, M. J., Knoblach, S. M., Sharif, N. A., Burt, D. R., Buterbaugh, G. G., & Fuson, K. S. (1993) · Annals of Neurology · doi:10.1002/ana.410330112 · Cited by 57
Localization of the human JUN protooncogene to chromosome region 1p31-32.
Haluska, F. G., Huebner, K., Isobe, M., Nishimura, T., Croce, C. M., & Vogt, P. K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2215 · Cited by 57
Self-citationInsertional Oncogenesis by Non-Acute Retroviruses: Implications for Gene Therapy
Fan, H., & Johnson, C. (2011) · Viruses · doi:10.3390/v3040398 · Cited by 60
“These include the cellular Ras [23–25], Raf [26,27], Myc [28,29], Fos [30,31], Jun [32,33], and Akt [34,35] proteins to name a few.”
BackgroundZhang, K., Chaillet, J. R., Perkins, L. A., Halazonetis, T. D., & Perrimon, N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6281 · Cited by 65
A new DNA-binding motif in the Skn-1 binding domain–DNA complex
Rupert, P. B., Daughdrill, G. W., Bowerman, B. A., & Matthews, B. W. (1998) · Nature Structural Biology · doi:10.1038/nsb0698-484 · Cited by 61
The Activation and Activity Control of AP‐1 (Fos/Jun)
Radler‐Pohl, A., Gebel, S., Sachsenmaier, C., König, H., Krämer, M., Oehler, T., STREILE, M., Ponta, H., Rapp, U. R., Rahmsdorf, H. J., et al. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb32277.x · Cited by 59
Estrogen regulates expression of the jun family of protooncogenes in the uterus
Chiappetta, C., Kirkland, J. L., Loose, D. S., Murthy, L. J., & Stancel, G. M. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90037-j · Cited by 60
Vandel, L., Montreau, N., Vial, E., Pfarr, C. M., Binetruy, B., & Castellazzi, M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.1881 · Cited by 57
Gold, M. R., Sanghera, J. S., Stewart, J., & Pelech, S. L. (1992) · Biochemical Journal · doi:10.1042/bj2870269 · Cited by 55
Lumelsky, N. L., & Forget, B. G. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.7.3528-3536.1991 · Cited by 56
“AP-1 binding usually results in activation of transcription of genes bearing this regulatory sequence element (11, 36).”
BackgroundGoodman, P. A., Niehoff, L. B., & Uckun, F. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17742 · Cited by 55
Lee, J. S., von der Ahe, D., Kiefer, B., & Nagamine, Y. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.15.3365 · Cited by 55
(1995) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1995.376.10.627 · Cited by 52
Wang, X., Repasky, E. A., & Liu, H.-T. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4529 · Cited by 54
Expression of c-jun protooncogene in human myelomonocytic cells
Bertani, A., Polentarutti, N., Sica, A., Rambaldi, A., Mantovani, A., & Colotta, F. (1989) · Blood · doi:10.1182/blood.v74.5.1811.1811 · Cited by 54
Roberts, M. R., Miskimins, W. K., & Ruddle, F. H. (1989) · Cell Regulation · doi:10.1091/mbc.1.1.151 · Cited by 54
Targeting c-Jun and JunB proteins as potential anticancer cell therapy
Gurzov, E. N., Bakiri, L., Alfaro, J. M., Wagner, E. F., & Izquierdo, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210690 · Cited by 53
“Originally, these proteins were identified as being the cellular counterparts of chicken- and mousetransforming viral genes, and therefore c-jun and c-fos were defined as proto-oncogenes (Curran and Teich, 1982; Curran et al., 1982; Bohmann et al., 1987; Rauscher et al., 1988).”
BackgroundLiu, J., Yan, J., Zhou, C., Ma, Q., Jin, Q., & Yang, Z. (2014) · Tumor Biology · doi:10.1007/s13277-014-2622-5 · Cited by 53
Regulatory roles of c-jun in H5N1 influenza virus replication and host inflammation
Xie, J., Zhang, S., Hu, Y., Li, D., Cui, J., Xue, J., Zhang, G., Khachigian, L. M., Wong, J. P., Sun, L., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.017 · Cited by 53
Hormonally inducible phosphorylation of a nuclear pool of ribosomal protein S6.
Franco, R., & Rosenfeld, M. G. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39566-3 · Cited by 53
Transcriptional control of c-junby retinoic acid
de Groot, R. P., Pals, C. E. G. M., & Kruijer, W. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.7.1585 · Cited by 56
Vaudano, E., Campbell, G., Hunt, S. P., & Lieberman, A. R. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00282.x · Cited by 54
(1994) · PubMed · Cited by 53
Anegón, I., Moreau, J., Godard, A., Jacques, Y., Peyrat, M., Hallet, M., Wong, G. G., & Soulillou, J. (1990) · Cellular Immunology · doi:10.1016/0008-8749(90)90161-j · Cited by 53
Galway, A., Oikawa, M., Ny, T., & Hsueh, A. J. W. (1989) · Endocrinology · doi:10.1210/endo-125-1-126 · Cited by 60
Characterization of the mouse junD promoter‐‐high basal level activity due to an octamer motif.
de Groot, R. P., Karperien, M., Pals, C. E. G. M., & Kruijer, W. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07792.x · Cited by 57
Phytoconstituents as apoptosis inducing agents: strategy to combat cancer
Kumar, M., Kaur, V., Kumar, S., & Kaur, S. (2015) · Cytotechnology · doi:10.1007/s10616-015-9897-2 · Cited by 59
Mehla, K., Balwani, S., Kulshreshtha, A., Nandi, D., Jaisankar, P., & Ghosh, B. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.07.068 · Cited by 55
Metadata
- Authors
- Bohmann, D., Bos, T. J., Admon, A., Nishimura, T., Vogt, P. K., & Tjian, R.
- Affiliations
- Howard Hughes Medical Institute (US)
- University of Southern California (US)
- Venue
- Science
- Published
- 1987-12-04
- Volume
- 238
- Issue
- 4832
- Pages
- 1386-1392
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2000371106
- Cited by
- 1,321
- References
- 31
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 7 · 2023: 5 · 2022: 5 · 2021: 7 · 2020: 5 · 2019: 8 · 2018: 5 · 2017: 5 · 2016: 4 · 2015: 12 · 2014: 8 · 2013: 13 · 2012: 4
- FWCI
- 58.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA-42564, CA-25417)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- c-Jun, proto-oncogenes, AP-1, transcription factors, v-Jun, GCN4, DNA-binding domain, sequence-specific DNA binding, enhancer binding proteins, phorbol ester, gene expression regulation, oncogene products, cancer, cell growth
- MeSH terms
- Proto-Oncogene Mas, Amino Acid Sequence, Antibodies, Avian Sarcoma Viruses, Base Sequence, Cross Reactions, DNA, DNA-Binding Proteins, Enhancer Elements, Genetic, Fungal Proteins, Gene Expression Regulation, Genes, Viral, Humans, Molecular Sequence Data, Oncogenes, Protein Kinases, Proto-Oncogene Proteins, Proto-Oncogenes, Recombinant Proteins, Retroviridae Proteins, Saccharomyces cerevisiae, Sequence Homology, Nucleic Acid, Transcription Factors, Transcription, Genetic, Proto-Oncogene Proteins c-jun, Oncogene Protein p65(gag-jun), Saccharomyces cerevisiae Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.